FIC Capital’s AbbVie ABBV Stock Holding History

FIC Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$258K	Sell	2,900 -100	-3%	-$7.61K	0.1%	104
2017 Q2	$218K	Sell	3,000 -350	-10%	-$23.5K	0.09%	109
2017 Q1	$218K	Sell	3,350 -250	-7%	-$15.7K	0.1%	106
2016 Q4	$225K	Sell	3,600 -1,350	-27%	-$82.4K	0.11%	102
2016 Q3	$312K	Sell	4,950 -650	-12%	-$42.1K	0.14%	100
2016 Q2	$347K	Hold	5,600	–	–	0.16%	97
2016 Q1	$320K	Hold	5,600	–	–	0.15%	90
2015 Q4	$332K	Sell	5,600 -6,500	-54%	-$374K	0.15%	96
2015 Q3	$658K	Hold	12,100	–	–	0.31%	72
2015 Q2	$813K	Buy	12,100 +600	+5%	+$39.2K	0.32%	77
2015 Q1	$673K	Sell	11,500 -500	-4%	-$30.2K	0.26%	90
2014 Q4	$785K	Hold	12,000	–	–	0.3%	90
2014 Q3	$693K	Sell	12,000 -2,100	-15%	-$117K	0.28%	97
2014 Q2	$796K	Hold	14,100	–	–	0.31%	94
2014 Q1	$725K	Hold	14,100	–	–	0.3%	99
2013 Q4	$745K	Sell	14,100 -300	-2%	-$14.7K	0.33%	102
2013 Q3	$644K	Hold	14,400	–	–	0.33%	101
2013 Q2	$595K	Buy	+14,400	New	+$630K	0.38%	85

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

FIC Capital's ABBV Position: Q3 2017 in Review

FIC Capital reduced its AbbVie (ABBV) stake by 3.3% in Q3 2017, selling an estimated $7.61K and leaving 2,900 shares worth $258K. The position accounts for 0.1% of the portfolio, ranked #104.

FIC Capital first reported a position in ABBV in Q2 2013 and has held it in 18 quarters since. The position peaked at $813K in Q2 2015. 1,797 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

FIC Capital held 2,900 shares of AbbVie worth $258K as of Q3 2017.
FIC Capital sold 100 AbbVie shares in Q3 2017, an estimated $7.61K.
AbbVie made up 0.1% of FIC Capital's portfolio in Q3 2017, its #104 holding.
FIC Capital first reported a position in AbbVie in Q2 2013 and has held it in 18 quarters since.
FIC Capital's AbbVie position peaked at $813K in Q2 2015.
1,797 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.